Randall B Brenner - Chief Development & Regulatory, Paratek Pharmaceuticals, Inc
As of December 15, 2021
Randall B Brenner Net Worth
- Net worth is estimated to be at least $1.14M
- Owns at least 253,530 units of Paratek Pharmaceuticals, Inc stock
- Sold an estimated value of $512.12K in the last 2 years at Paratek Pharmaceuticals, Inc
Randall B Brenner Trading
- Largest sale of shares was 27,894 units , worth over $120.54K on December 15, 2021
- In total has made about 11 transactions over 2 years
- Usually trades in December, with the busiest year in 2020 and 2021
Randall B Brenner
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Randall B Brenner Mailing Address
- Mailing address is C/o Paratek Pharmaceuticals, Inc. 75 Park Plaza, 4th Floor Boston MA 02116 MA
Paratek Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Evan Loh, M.D. | 2020 | $575,000 | - | $505,440 | $431,250 | $22,921 | $1,534,611 |
| Evan Loh, M.D. | 2019 | $520,000 | - | $1,352,100 | $364,375 | $22,521 | $2,258,996 |
| Evan Loh, M.D. | 2018 | $480,000 | - | $1,011,725 | $288,000 | $21,434 | $1,801,159 |
| Michael F. Bigham | 2020 | $500,000 | - | $473,850 | $375,000 | $24,703 | $1,373,553 |
| Michael F. Bigham | 2019 | $515,000 | - | $1,352,100 | $343,750 | $22,928 | $2,233,778 |
| Michael F. Bigham | 2018 | $500,000 | - | $1,089,550 | $330,000 | $22,890 | $1,942,440 |
| Adam Woodrow | 2020 | $445,000 | - | $236,925 | $250,313 | $16,552 | $948,790 |
| Adam Woodrow | 2019 | $415,000 | $48,375 | $676,050 | $193,500 | $15,330 | $1,348,225 |
| Adam Woodrow | 2018 | $365,000 | $35,040 | $505,862 | $140,160 | $15,369 | $1,061,431 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1178711/000120677421001229/prtk3887701-def14a.htm
Paratek Pharmaceuticals, Inc Insider Trading
- The most recent transaction was 31,500 units sold on December 15, 2021 by Michael Bigham worth over $136.13K
- In the last 6 years, insiders at Paratek Pharmaceuticals, Inc sold an estimated value of $8.11M and bought an estimated value of $12.81M
- The most active traders are Evan Loh, CEO, Michael Bigham, Exec. Chairman the Board, and William M Haskel, CLO
- Insider trading is most common in February, with the busiest year in 2018
Paratek Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||